Safety and Efficacy of Nemolizumab in PN

Clinical trial NCT03181503 · COMPLETED

Trial details

NCT number: NCT03181503
Sponsor: Galderma R&D
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prurigo Nodularis

Start date: 2017-10-02
Primary completion: 2018-09-26
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.